Cargando…
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568855/ https://www.ncbi.nlm.nih.gov/pubmed/34536122 http://dx.doi.org/10.1007/s00401-021-02369-1 |
| _version_ | 1784594519480598528 |
|---|---|
| author | Sievers, Philipp Stichel, Damian Sill, Martin Schrimpf, Daniel Sturm, Dominik Selt, Florian Ecker, Jonas Kazdal, Daniel Miele, Evelina Kranendonk, Mariëtte E. G. Tops, Bastiaan B. J. Kohlhof-Meinecke, Patricia Beschorner, Rudi Kramm, Christof M. Hasselblatt, Martin Reifenberger, Guido Capper, David Wesseling, Pieter Stenzinger, Albrecht Milde, Till Korshunov, Andrey Witt, Olaf Pfister, Stefan M. Wick, Wolfgang von Deimling, Andreas Jones, David T. W. Sahm, Felix |
| author_facet | Sievers, Philipp Stichel, Damian Sill, Martin Schrimpf, Daniel Sturm, Dominik Selt, Florian Ecker, Jonas Kazdal, Daniel Miele, Evelina Kranendonk, Mariëtte E. G. Tops, Bastiaan B. J. Kohlhof-Meinecke, Patricia Beschorner, Rudi Kramm, Christof M. Hasselblatt, Martin Reifenberger, Guido Capper, David Wesseling, Pieter Stenzinger, Albrecht Milde, Till Korshunov, Andrey Witt, Olaf Pfister, Stefan M. Wick, Wolfgang von Deimling, Andreas Jones, David T. W. Sahm, Felix |
| author_sort | Sievers, Philipp |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8568855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85688552021-11-15 GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types Sievers, Philipp Stichel, Damian Sill, Martin Schrimpf, Daniel Sturm, Dominik Selt, Florian Ecker, Jonas Kazdal, Daniel Miele, Evelina Kranendonk, Mariëtte E. G. Tops, Bastiaan B. J. Kohlhof-Meinecke, Patricia Beschorner, Rudi Kramm, Christof M. Hasselblatt, Martin Reifenberger, Guido Capper, David Wesseling, Pieter Stenzinger, Albrecht Milde, Till Korshunov, Andrey Witt, Olaf Pfister, Stefan M. Wick, Wolfgang von Deimling, Andreas Jones, David T. W. Sahm, Felix Acta Neuropathol Correspondence Springer Berlin Heidelberg 2021-09-18 2021 /pmc/articles/PMC8568855/ /pubmed/34536122 http://dx.doi.org/10.1007/s00401-021-02369-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Sievers, Philipp Stichel, Damian Sill, Martin Schrimpf, Daniel Sturm, Dominik Selt, Florian Ecker, Jonas Kazdal, Daniel Miele, Evelina Kranendonk, Mariëtte E. G. Tops, Bastiaan B. J. Kohlhof-Meinecke, Patricia Beschorner, Rudi Kramm, Christof M. Hasselblatt, Martin Reifenberger, Guido Capper, David Wesseling, Pieter Stenzinger, Albrecht Milde, Till Korshunov, Andrey Witt, Olaf Pfister, Stefan M. Wick, Wolfgang von Deimling, Andreas Jones, David T. W. Sahm, Felix GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types |
| title | GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types |
| title_full | GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types |
| title_fullStr | GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types |
| title_full_unstemmed | GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types |
| title_short | GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types |
| title_sort | gopc:ros1 and other ros1 fusions represent a rare but recurrent drug target in a variety of glioma types |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568855/ https://www.ncbi.nlm.nih.gov/pubmed/34536122 http://dx.doi.org/10.1007/s00401-021-02369-1 |
| work_keys_str_mv | AT sieversphilipp gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT sticheldamian gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT sillmartin gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT schrimpfdaniel gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT sturmdominik gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT seltflorian gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT eckerjonas gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT kazdaldaniel gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT mieleevelina gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT kranendonkmarietteeg gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT topsbastiaanbj gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT kohlhofmeineckepatricia gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT beschornerrudi gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT krammchristofm gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT hasselblattmartin gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT reifenbergerguido gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT capperdavid gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT wesselingpieter gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT stenzingeralbrecht gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT mildetill gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT korshunovandrey gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT wittolaf gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT pfisterstefanm gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT wickwolfgang gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT vondeimlingandreas gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT jonesdavidtw gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes AT sahmfelix gopcros1andotherros1fusionsrepresentararebutrecurrentdrugtargetinavarietyofgliomatypes |